Literature DB >> 16625098

Glycogenic hepatopathy: an underrecognized hepatic complication of diabetes mellitus.

Michael Torbenson1, Yunn-Yi Chen, Elizabeth Brunt, Oscar W Cummings, Marcia Gottfried, Shriram Jakate, Yao-Chang Liu, Matthew M Yeh, Linda Ferrell.   

Abstract

Reported are the clinical and pathologic features of glycogenic hepatopathy, a pathologic overloading of hepatocytes with glycogen that is associated with poorly controlled diabetes mellitus. Fourteen cases were studied by stains, including hematoxylin and eosin, trichrome, periodic acid-Schiff, and periodic acid-Schiff with diastase. Ultrastructural analysis was performed in 2 cases. Medical records were reviewed for clinical presentations, laboratory findings, and clinical outcomes. The individuals ranged from 8 to 25 years of age. All had type I diabetes mellitus with poor glycemic control. The clinical presentations included hepatomegaly, abdominal pain, and elevated transaminases (range, 50-1600 IU/L). The transaminases were dramatically elevated in 3 cases to greater than 10 times the upper limit of normal. All biopsies showed diffusely pale staining hepatocytes on hematoxylin and eosin stains, with excessive glycogen accumulation demonstrated by periodic acid-Schiff stains. Ultrastructural examination revealed marked glycogen accumulation in the cytoplasm and nuclei. Most cases showed no evidence for fatty liver disease: steatosis was absent in 12 of 14 cases, simple steatosis was seen in 1 of 14 cases, and mild steatohepatitis was present in 1 of 14 cases. Mallory hyaline was absent in all cases, acidophil bodies were only rarely seen, and inflammation was absent or minimally present. Fibrosis was typically absent, with only 2 cases demonstrating focal mild fibrosis. Three patients had adequate follow-up and demonstrated improvement of liver enzyme levels with control of blood glucose. We conclude that glycogenic hepatopathy can cause hepatomegaly and significant transaminase elevations in individuals with type I diabetes mellitus. The pathology is distinct from steatohepatitis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16625098     DOI: 10.1097/00000478-200604000-00012

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  52 in total

1.  Association of diffuse liver glycogenosis and mild focal macrovesicular steatosis in a patient with poorly controlled type 1 diabetes.

Authors:  A Martocchia; M G Risicato; C Mattioli; M Antonelli; L Ruco; P Falaschi
Journal:  Intern Emerg Med       Date:  2008-02-09       Impact factor: 3.397

Review 2.  Fatty liver disease in diabetes mellitus.

Authors:  Harikrashna B Bhatt; Robert J Smith
Journal:  Hepatobiliary Surg Nutr       Date:  2015-04       Impact factor: 7.293

3.  Persistent lactic acidosis in the Mauriac syndrome in type 1 diabetes mellitus.

Authors:  Abinash Subedi; Vishnu Charan Suresh Kumar; Anuj Sharma; Gilles Hoilat; Savio John
Journal:  Proc (Bayl Univ Med Cent)       Date:  2021-01-11

Review 4.  Drug-induced Liver Injury: The Hepatic Pathologist's Approach.

Authors:  David E Kleiner
Journal:  Gastroenterol Clin North Am       Date:  2017-06       Impact factor: 3.806

5.  Glycogenic hepatopathy as a cause of severe deranged liver enzymes in a young patient with type 1 diabetes mellitus.

Authors:  Kalliopi Azariadis; Nikolaos K Gatselis; George K Koukoulis; Georgios N Dalekos
Journal:  BMJ Case Rep       Date:  2019-03-20

6.  Hepatic arteriolosclerosis: a small-vessel complication of diabetes and hypertension.

Authors:  Maya Balakrishnan; Guadalupe Garcia-Tsao; Yanghong Deng; Maria Ciarleglio; Dhanpat Jain
Journal:  Am J Surg Pathol       Date:  2015-07       Impact factor: 6.394

Review 7.  Hepatic glycogenosis: An underdiagnosed complication of diabetes mellitus?

Authors:  María Teresa Julián; Núria Alonso; Isabel Ojanguren; Eduarda Pizarro; Enric Ballestar; Manel Puig-Domingo
Journal:  World J Diabetes       Date:  2015-03-15

8.  GLYCOGENIC HEPATOPATHY: A COMPLICATION OF UNCONTROLLED DIABETES.

Authors:  Medha Satyarengga; Yelena Zubatov; Sylvaine Frances; Gopal Narayanswami; Rodolfo J Galindo
Journal:  AACE Clin Case Rep       Date:  2017

Review 9.  Recent Advances in the Histopathology of Drug-Induced Liver Injury.

Authors:  David E Kleiner
Journal:  Surg Pathol Clin       Date:  2018-06

Review 10.  Prognostic implication of liver histology in patients with nonalcoholic fatty liver disease in diabetes.

Authors:  Iliana Doycheva; Niraj Patel; Michael Peterson; Rohit Loomba
Journal:  J Diabetes Complications       Date:  2013-01-09       Impact factor: 2.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.